<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36314424</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Clinical heterogeneity in a family with flail arm syndrome and review of hnRNPA1-related spectrum.</ArticleTitle><Pagination><StartPage>1910</StartPage><EndPage>1917</EndPage><MedlinePgn>1910-1917</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51682</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Flail arm syndrome (FAS) is one of the atypical subtypes of amyotrophic lateral sclerosis (ALS). Mutations in hnRNPA1 encoding heterogeneous nuclear ribonucleoprotein (hnRNP) A1 are a rare genetic cause of ALS. Herein, marked clinical heterogeneity of FAS in a pedigree with a known hnRNPA1 variant was described to raise early awareness of the ALS variant. Furtherly, a literature review of the hnRNPA1-related spectrum was made to summarize the clinical and genetic characteristics.</AbstractText><AbstractText Label="METHODS">Detailed clinical evaluation, muscle pathology, and whole-exome sequencing were performed. The sequence and co-segregation of the mutation among the family members were confirmed by Sanger sequencing.</AbstractText><AbstractText Label="RESULTS">The great clinical variability was found in a FAS pedigree. Muscle pathology revealed a cluster distribution of angulated or rounded atrophic fibers, accompanied by significant multi-nucleus aggregation. Immunohistochemical staining showed that mutant hnRNPA1 proteins accumulated in muscle fiber cytoplasm. Exome sequencing identified a documented variant in hnRNPA1 gene c.1018C&#x2009;&gt;&#x2009;T (p.P340S), which co-segregated with disease in the family. Besides, highly phenotypic heterogeneity was also found in other hnRNPA1-related diseases.</AbstractText><AbstractText Label="INTERPRETATION">We described a Chinese pedigree with hnRNPA1-related FAS, which showed significant clinical variability among the intrafamilial members. FAS is a relatively milder variant of ALS, due to the highly heterogeneous clinical spectrum, early observation is of paramount importance. In addition, the highly phenotypic heterogeneity and molecular genetic mechanism of the hnRNPA1-related spectrum are still beyond fully understood. Further, the detailed molecular mechanism underlying the clinical diversity is warranted to be explored.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Han</LastName><ForeName>Xiaochen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Sixth Medical Center of PLA General Hospital, Beijing, 100048, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhan</LastName><ForeName>Feixia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 200233, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Yuxin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Sixth Medical Center of PLA General Hospital, Beijing, 100048, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Li</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1742-9877</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 200233, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jianguo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Sixth Medical Center of PLA General Hospital, Beijing, 100048, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4395-945X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Sixth Medical Center of PLA General Hospital, Beijing, 100048, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034481">Heterogeneous-Nuclear Ribonucleoprotein Group A-B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076245">Heterogeneous Nuclear Ribonucleoprotein A1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034481" MajorTopicYN="Y">Heterogeneous-Nuclear Ribonucleoprotein Group A-B</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076245" MajorTopicYN="N">Heterogeneous Nuclear Ribonucleoprotein A1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073359" MajorTopicYN="N">Exome Sequencing</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36314424</ArticleId><ArticleId IdType="pmc">PMC9735363</ArticleId><ArticleId IdType="doi">10.1002/acn3.51682</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, et&#xa0;al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084&#x2010;2098.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Hardiman O, et&#xa0;al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10(5&#x2010;6):310&#x2010;323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10(11):661&#x2010;670.</Citation><ArticleIdList><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera LC, Mathers S, Talman P, et&#xa0;al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009;72(12):1087&#x2010;1094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2821838</ArticleId><ArticleId IdType="pubmed">19307543</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto W, Debona R, Nunes PP, et&#xa0;al. Atypical Motor Neuron Disease variants: still a diagnostic challenge in Neurology. Rev Neurol (Paris). 2019;175(4):221&#x2010;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">30846210</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamez J, Cervera C, Codina A. Flail arm syndrome of Vulpian&#x2010;Bernhart's form of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1999;67(2):258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1736499</ArticleId><ArticleId IdType="pubmed">10475767</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu MT, Ellis CM, Al&#x2010;Chalabi A, Leigh PN, Shaw CE. Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1998;65(6):950&#x2010;951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2170397</ArticleId><ArticleId IdType="pubmed">9854987</ArticleId></ArticleIdList></Reference><Reference><Citation>Hino S, Sasaki S. Flail arm syndrome with cytoplasmic vacuoles in remaining anterior horn motor neurons: a peculiar variant of amyotrophic lateral sclerosis. Neuropathology. 2015;35(6):582&#x2010;586.</Citation><ArticleIdList><ArticleId IdType="pubmed">26149762</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Kiernan MC. Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2007;78(8):849&#x2010;852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2117729</ArticleId><ArticleId IdType="pubmed">17210625</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Iwata M. Atypical form of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1999;66(5):581&#x2010;585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1736328</ArticleId><ArticleId IdType="pubmed">10209167</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Iwata M. Motor neuron disease with predominantly upper extremity involvement: a clinicopathological study. Acta Neuropathol. 1999;98(6):645&#x2010;650.</Citation><ArticleIdList><ArticleId IdType="pubmed">10603042</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Tang L, Fan D. Twelve&#x2010;month duration as an appropriate criterion for flail arm syndrome. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(1&#x2010;2):29&#x2010;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">31523989</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chio A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17(1):94&#x2010;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison AF, Shorter J. RNA&#x2010;binding proteins with prion&#x2010;like domains in health and disease. Biochem J. 2017;474(8):1417&#x2010;1438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5639257</ArticleId><ArticleId IdType="pubmed">28389532</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K, Martinez FJ, Yeo GW. Genetic mutations in RNA&#x2010;binding proteins and their roles in ALS. Hum Genet. 2017;136(9):1193&#x2010;1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Nussbacher JK, Tabet R, Yeo GW, Lagier&#x2010;Tourenne C. Disruption of RNA metabolism in neurological diseases and emerging therapeutic interventions. Neuron. 2019;102(2):294&#x2010;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6545120</ArticleId><ArticleId IdType="pubmed">30998900</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Kim NC, Wang YD, et&#xa0;al. Mutations in prion&#x2010;like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495(7442):467&#x2010;473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293&#x2010;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubers A, Hildebrandt V, Petri S, et&#xa0;al. Clinical features and differential diagnosis of flail arm syndrome. J Neurol. 2016;263(2):390&#x2010;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">26705123</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S, Aziz N, Bale S, et&#xa0;al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405&#x2010;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Shu S, Wang RR, et&#xa0;al. Whole&#x2010;exome sequencing identifies a missense mutation in hnRNPA1 in a family with flail arm ALS. Neurology. 2016;87(17):1763&#x2010;1769.</Citation><ArticleIdList><ArticleId IdType="pubmed">27694260</ArticleId></ArticleIdList></Reference><Reference><Citation>Couratier P, Lautrette G, Luna JA, Corcia P. Phenotypic variability in amyotrophic lateral sclerosis. Rev Neurol (Paris). 2021;177(5):536&#x2010;543.</Citation><ArticleIdList><ArticleId IdType="pubmed">33902945</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, et&#xa0;al. Ubiquitinated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130&#x2010;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman SA, Hardiman O, Al&#x2010;Chalabi A, et&#xa0;al. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21(5):465&#x2010;479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9513754</ArticleId><ArticleId IdType="pubmed">35334234</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Zhang B, Chen R, et&#xa0;al. Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China. J Neurol Neurosurg Psychiatry. 2015;86(10):1075&#x2010;1081.</Citation><ArticleIdList><ArticleId IdType="pubmed">26124198</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornitzer J, Abdulrazeq HF, Zaidi M, et&#xa0;al. Differentiating flail limb syndrome from amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2020;99(10):895&#x2010;901.</Citation><ArticleIdList><ArticleId IdType="pubmed">32251109</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G, Gautier O, Tassoni&#x2010;Tsuchida E, Ma XR, Gitler AD. ALS genetics: gains, losses, and implications for future therapies. Neuron. 2020;108(5):822&#x2010;842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Picchiarelli G, Dupuis L. Role of RNA binding proteins with prion&#x2010;like domains in muscle and neuromuscular diseases. Cell Stress. 2020;4(4):76&#x2010;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146060</ArticleId><ArticleId IdType="pubmed">32292882</ArticleId></ArticleIdList></Reference><Reference><Citation>March ZM, King OD, Shorter J. Prion&#x2010;like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease. Brain Res. 2016;1647:9&#x2010;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003744</ArticleId><ArticleId IdType="pubmed">26996412</ArticleId></ArticleIdList></Reference><Reference><Citation>Purice MD, Taylor JP. Linking hnRNP function to ALS and FTD pathology. Front Neurosci. 2018;12:326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5962818</ArticleId><ArticleId IdType="pubmed">29867335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekenstein U, Soreq H. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post&#x2010;transcriptional regulatory roles. Mol Cell Neurosci. 2013;56:436&#x2010;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">23247072</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Zhao K, Xia W, et&#xa0;al. The nuclear localization sequence mediates hnRNPA1 amyloid fibril formation revealed by cryoEM structure. Nat Commun. 2020;11(1):6349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7733464</ArticleId><ArticleId IdType="pubmed">33311513</ArticleId></ArticleIdList></Reference><Reference><Citation>Beijer D, Kim HJ, Guo L, et&#xa0;al. Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentation. JCI Insight. 2021;6(14):e148363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8410042</ArticleId><ArticleId IdType="pubmed">34291734</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruse H, Ishiura H, Mitsui J, et&#xa0;al. Molecular epidemiological study of familial amyotrophic lateral sclerosis in Japanese population by whole&#x2010;exome sequencing and identification of novel HNRNPA1 mutation. Neurobiol Aging. 2018;61:255.e9&#x2010;255.e16.</Citation><ArticleIdList><ArticleId IdType="pubmed">29033165</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilpin KM, Chang L, Monteiro MJ. ALS&#x2010;linked mutations in ubiquilin&#x2010;2 or hnRNPA1 reduce interaction between ubiquilin&#x2010;2 and hnRNPA1. Hum Mol Genet. 2015;24(9):2565&#x2010;2577.</Citation><ArticleIdList><ArticleId IdType="pubmed">25616961</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda H, Hamasaki H, Wakamiya T, et&#xa0;al. Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP&#x2010;43&#x2010;positive inclusions. Neuropathology. 2015;35(1):37&#x2010;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">25338872</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H, Matsuoka M. hnRNPA1 autoregulates its own mRNA expression to remain non&#x2010;cytotoxic. Mol Cell Biochem. 2017;427(1&#x2013;2):123&#x2010;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">28000042</ArticleId></ArticleIdList></Reference><Reference><Citation>Fifita JA, Zhang KY, Galper J, et&#xa0;al. Genetic and pathological assessment of hnRNPA1, hnRNPA2/B1, and hnRNPA3 in familial and sporadic amyotrophic lateral sclerosis. Neurodegener Dis. 2017;17(6):304&#x2010;312.</Citation><ArticleIdList><ArticleId IdType="pubmed">29131108</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelen M, Visser AE, Overste DJ, et&#xa0;al. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy. Neurobiol Aging. 2014;35(8):1956.e9&#x2010;1959.e11.</Citation><ArticleIdList><ArticleId IdType="pubmed">24612671</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumi R, Warita H, Niihori T, et&#xa0;al. Isolated inclusion body myopathy caused by a multisystem proteinopathy&#x2010;linked hnRNPA1 mutation. Neurol Genet. 2015;1(3):e23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4809462</ArticleId><ArticleId IdType="pubmed">27066560</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackman P, Rusanen SM, Johari M, et&#xa0;al. Dominant distal myopathy 3 (MPD3) caused by a deletion in the HNRNPA1 gene. Neurol Genet. 2021;7(6):e632.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8552285</ArticleId><ArticleId IdType="pubmed">34722876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahjneh I, Haravuori H, Paetau A, et&#xa0;al. A distinct phenotype of distal myopathy in a large Finnish family. Neurology. 2003;61(1):87&#x2010;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">12847162</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke JWE, Thibault PA, Salapa HE, Kim DE, Hutchinson C, Levin MC. Multiple sclerosis&#x2010;associated hnRNPA1 mutations alter hnRNPA1 dynamics and influence stress granule formation. Int J Mol Sci. 2021;22(6):2909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7998649</ArticleId><ArticleId IdType="pubmed">33809384</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>